Post Profile

U.S. government health plans spent over $1 billion on EpiPens over five years

(Reuters) - U.S. government health plans spent more than $1 billion on Mylan NV's EpiPen emergency allergic reaction treatment between 2011 and 2015, according to figures released by the Centers for Medicare and Medicaid Services on Wednesday.
read more


Related Posts

Parent bloggers question role in Mylan’s EpiPen schools push

Health : Reuters: Health

CHICAGO (Reuters) - When Mylan NV recruited food allergy bloggers to learn about its campaign to get allergic shock antidotes into schools, many were eager to join the maker of the EpiPens they carry in purses and stash in book bags...

West Virginia investigating Mylan over EpiPen pricing

Health : Reuters: Health

NEW YORK (Reuters) - The state of West Virginia is investigating whether Mylan NV violated antitrust law or defrauded the state's Medicaid program in connection with its EpiPen device.

Mylan reiterates profit on EpiPen two-pack in U.S.

Health : Reuters: Health

(Reuters) - Under fire generic drugmaker Mylan NV reiterated it makes a net profit of $104, after taxes, for a pair of its EpiPen emergency allergy treatment sold in the United States, the company said in a filing on Monday.

U.S. lawmakers question Mylan's Medicaid EpiPen rebates

Health : Reuters: Health

(Reuters) - Two key U.S. congressional committee members on Friday called for an investigation into whether Mylan NV, under fire for raising the price of its EpiPen device, overcharged the government's low-income healthcare program ...

CONFIRMED: The maker of EpiPen overcharged the government and lawmakers are furious

Business & Finance : Business Insider: Clusterstock

The Centers for Medicare & Medicaid Services (CMS) confirmed to lawmakers that Mylan, the drug company that makes EpiPen, has been overcharging the government for the life-saving allergy medication. And naturally, lawmakers are furi...


Copyright © 2016 Regator, LLC